BGB-A445
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BGB-A445, covering 2025-10-03 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors. [Phase 1, Phase 2]